nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Rifampicin—leprosy	0.128	0.152	CbGbCtD
Bupropion—CYP2E1—Thalidomide—leprosy	0.0872	0.104	CbGbCtD
Bupropion—CYP2E1—Rifampicin—leprosy	0.0845	0.101	CbGbCtD
Bupropion—CYP2B6—Rifampicin—leprosy	0.0833	0.0992	CbGbCtD
Bupropion—CYP2E1—Dapsone—leprosy	0.0697	0.083	CbGbCtD
Bupropion—CYP2C8—Rifampicin—leprosy	0.0631	0.0751	CbGbCtD
Bupropion—CYP2C8—Dapsone—leprosy	0.0521	0.062	CbGbCtD
Bupropion—CYP1A2—Thalidomide—leprosy	0.0505	0.0601	CbGbCtD
Bupropion—CYP1A2—Rifampicin—leprosy	0.0489	0.0582	CbGbCtD
Bupropion—CYP2C9—Thalidomide—leprosy	0.0455	0.0541	CbGbCtD
Bupropion—CYP2C9—Rifampicin—leprosy	0.044	0.0524	CbGbCtD
Bupropion—CYP2C9—Dapsone—leprosy	0.0363	0.0433	CbGbCtD
Bupropion—CYP3A4—Rifampicin—leprosy	0.0256	0.0305	CbGbCtD
Bupropion—CYP3A4—Dapsone—leprosy	0.0211	0.0252	CbGbCtD
Bupropion—Joint sprain—Dapsone—leprosy	0.00795	0.051	CcSEcCtD
Bupropion—Nerve injury—Dapsone—leprosy	0.00731	0.0469	CcSEcCtD
Bupropion—Ligament sprain—Dapsone—leprosy	0.00632	0.0405	CcSEcCtD
Bupropion—Menopause—Thalidomide—leprosy	0.0036	0.0231	CcSEcCtD
Bupropion—Application site reaction—Dapsone—leprosy	0.0034	0.0218	CcSEcCtD
Bupropion—Swelling face—Dapsone—leprosy	0.00335	0.0215	CcSEcCtD
Bupropion—Enuresis—Thalidomide—leprosy	0.00286	0.0183	CcSEcCtD
Bupropion—Suicide attempt—Dapsone—leprosy	0.00281	0.018	CcSEcCtD
Bupropion—Intestinal perforation—Thalidomide—leprosy	0.00207	0.0133	CcSEcCtD
Bupropion—Parkinsonism—Thalidomide—leprosy	0.0018	0.0115	CcSEcCtD
Bupropion—Altered state of consciousness—Thalidomide—leprosy	0.00177	0.0113	CcSEcCtD
Bupropion—Paraesthesia oral—Thalidomide—leprosy	0.00174	0.0112	CcSEcCtD
Bupropion—Hostility—Thalidomide—leprosy	0.00148	0.00946	CcSEcCtD
Bupropion—Sexual dysfunction—Thalidomide—leprosy	0.00146	0.00935	CcSEcCtD
Bupropion—Suicide attempt—Thalidomide—leprosy	0.00144	0.00923	CcSEcCtD
Bupropion—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00141	0.00902	CcSEcCtD
Bupropion—Gastric ulcer—Thalidomide—leprosy	0.00141	0.00902	CcSEcCtD
Bupropion—Toothache—Thalidomide—leprosy	0.00134	0.00861	CcSEcCtD
Bupropion—Tooth disorder—Thalidomide—leprosy	0.00126	0.00808	CcSEcCtD
Bupropion—Menstrual disorder—Thalidomide—leprosy	0.0012	0.00769	CcSEcCtD
Bupropion—Neuralgia—Thalidomide—leprosy	0.00118	0.00754	CcSEcCtD
Bupropion—Metrorrhagia—Thalidomide—leprosy	0.00114	0.00734	CcSEcCtD
Bupropion—Psychotic disorder—Dapsone—leprosy	0.00113	0.00726	CcSEcCtD
Bupropion—Amblyopia—Thalidomide—leprosy	0.00106	0.00679	CcSEcCtD
Bupropion—Hyperaesthesia—Thalidomide—leprosy	0.00104	0.00668	CcSEcCtD
Bupropion—Nasopharyngitis—Dapsone—leprosy	0.00104	0.00664	CcSEcCtD
Bupropion—Muscular weakness—Dapsone—leprosy	0.00102	0.00655	CcSEcCtD
Bupropion—Influenza—Dapsone—leprosy	0.001	0.00642	CcSEcCtD
Bupropion—Pancreatitis—Dapsone—leprosy	0.000982	0.0063	CcSEcCtD
Bupropion—CHRNA3—skin epidermis—leprosy	0.000978	0.248	CbGeAlD
Bupropion—Acne—Thalidomide—leprosy	0.000971	0.00623	CcSEcCtD
Bupropion—Amenorrhoea—Thalidomide—leprosy	0.00093	0.00596	CcSEcCtD
Bupropion—Vasodilation procedure—Thalidomide—leprosy	0.00093	0.00596	CcSEcCtD
Bupropion—Vasodilation—Thalidomide—leprosy	0.00093	0.00596	CcSEcCtD
Bupropion—Accidental injury—Thalidomide—leprosy	0.000923	0.00592	CcSEcCtD
Bupropion—Photosensitivity reaction—Dapsone—leprosy	0.000914	0.00586	CcSEcCtD
Bupropion—Musculoskeletal stiffness—Thalidomide—leprosy	0.000911	0.00584	CcSEcCtD
Bupropion—Thinking abnormal—Thalidomide—leprosy	0.000892	0.00572	CcSEcCtD
Bupropion—Neuropathy peripheral—Dapsone—leprosy	0.000875	0.00561	CcSEcCtD
Bupropion—Leukocytosis—Thalidomide—leprosy	0.000869	0.00558	CcSEcCtD
Bupropion—Dyskinesia—Thalidomide—leprosy	0.000869	0.00558	CcSEcCtD
Bupropion—Hypercholesterolaemia—Thalidomide—leprosy	0.000864	0.00554	CcSEcCtD
Bupropion—Hearing impaired—Thalidomide—leprosy	0.000858	0.0055	CcSEcCtD
Bupropion—Sinusitis—Dapsone—leprosy	0.000838	0.00537	CcSEcCtD
Bupropion—Coordination abnormal—Thalidomide—leprosy	0.000832	0.00534	CcSEcCtD
Bupropion—Neck pain—Thalidomide—leprosy	0.000827	0.0053	CcSEcCtD
Bupropion—Hepatocellular injury—Thalidomide—leprosy	0.000817	0.00524	CcSEcCtD
Bupropion—Pulmonary embolism—Thalidomide—leprosy	0.000817	0.00524	CcSEcCtD
Bupropion—Eructation—Thalidomide—leprosy	0.000803	0.00515	CcSEcCtD
Bupropion—Pharyngitis—Dapsone—leprosy	0.000795	0.0051	CcSEcCtD
Bupropion—Depressed level of consciousness—Thalidomide—leprosy	0.000789	0.00506	CcSEcCtD
Bupropion—Colitis—Thalidomide—leprosy	0.000784	0.00503	CcSEcCtD
Bupropion—Neuropathy—Thalidomide—leprosy	0.000767	0.00492	CcSEcCtD
Bupropion—Dry eye—Thalidomide—leprosy	0.000755	0.00484	CcSEcCtD
Bupropion—Cramps of lower extremities—Thalidomide—leprosy	0.000751	0.00481	CcSEcCtD
Bupropion—Tinnitus—Dapsone—leprosy	0.000747	0.00479	CcSEcCtD
Bupropion—Oesophagitis—Thalidomide—leprosy	0.000747	0.00479	CcSEcCtD
Bupropion—Rash maculo-papular—Thalidomide—leprosy	0.000743	0.00476	CcSEcCtD
Bupropion—Gynaecomastia—Thalidomide—leprosy	0.000731	0.00469	CcSEcCtD
Bupropion—Hypertonia—Thalidomide—leprosy	0.000716	0.00459	CcSEcCtD
Bupropion—Hyperkinesia—Thalidomide—leprosy	0.000713	0.00457	CcSEcCtD
Bupropion—Mental disability—Thalidomide—leprosy	0.000709	0.00455	CcSEcCtD
Bupropion—Euphoric mood—Thalidomide—leprosy	0.000702	0.0045	CcSEcCtD
Bupropion—Lymphadenopathy—Thalidomide—leprosy	0.000695	0.00446	CcSEcCtD
Bupropion—Photosensitivity—Thalidomide—leprosy	0.000675	0.00433	CcSEcCtD
Bupropion—Gastroenteritis—Thalidomide—leprosy	0.000669	0.00429	CcSEcCtD
Bupropion—Deafness—Thalidomide—leprosy	0.000663	0.00425	CcSEcCtD
Bupropion—Eczema—Thalidomide—leprosy	0.00066	0.00423	CcSEcCtD
Bupropion—Vision blurred—Dapsone—leprosy	0.000658	0.00422	CcSEcCtD
Bupropion—Eye pain—Thalidomide—leprosy	0.000657	0.00421	CcSEcCtD
Bupropion—Injury—Thalidomide—leprosy	0.000645	0.00414	CcSEcCtD
Bupropion—Libido decreased—Thalidomide—leprosy	0.00064	0.0041	CcSEcCtD
Bupropion—Amnesia—Thalidomide—leprosy	0.000631	0.00405	CcSEcCtD
Bupropion—Increased appetite—Thalidomide—leprosy	0.000631	0.00405	CcSEcCtD
Bupropion—Dermatitis exfoliative—Thalidomide—leprosy	0.000629	0.00403	CcSEcCtD
Bupropion—Vertigo—Dapsone—leprosy	0.000627	0.00402	CcSEcCtD
Bupropion—Visual disturbance—Thalidomide—leprosy	0.000626	0.00401	CcSEcCtD
Bupropion—Arthritis—Thalidomide—leprosy	0.00061	0.00391	CcSEcCtD
Bupropion—Cough—Dapsone—leprosy	0.000609	0.0039	CcSEcCtD
Bupropion—Hypoglycaemia—Thalidomide—leprosy	0.000608	0.0039	CcSEcCtD
Bupropion—Cerebrovascular accident—Thalidomide—leprosy	0.000605	0.00388	CcSEcCtD
Bupropion—Lethargy—Thalidomide—leprosy	0.000605	0.00388	CcSEcCtD
Bupropion—Pain in extremity—Thalidomide—leprosy	0.000593	0.0038	CcSEcCtD
Bupropion—Diplopia—Thalidomide—leprosy	0.000593	0.0038	CcSEcCtD
Bupropion—Osteoarthritis—Thalidomide—leprosy	0.000593	0.0038	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000593	0.0038	CcSEcCtD
Bupropion—Disturbance in sexual arousal—Thalidomide—leprosy	0.000588	0.00377	CcSEcCtD
Bupropion—Migraine—Thalidomide—leprosy	0.000584	0.00374	CcSEcCtD
Bupropion—Affect lability—Thalidomide—leprosy	0.000584	0.00374	CcSEcCtD
Bupropion—Psychotic disorder—Thalidomide—leprosy	0.000579	0.00371	CcSEcCtD
Bupropion—Face oedema—Thalidomide—leprosy	0.000573	0.00367	CcSEcCtD
Bupropion—Mood swings—Thalidomide—leprosy	0.000562	0.0036	CcSEcCtD
Bupropion—Ataxia—Thalidomide—leprosy	0.000558	0.00358	CcSEcCtD
Bupropion—Tachycardia—Dapsone—leprosy	0.000556	0.00356	CcSEcCtD
Bupropion—Dehydration—Thalidomide—leprosy	0.000552	0.00354	CcSEcCtD
Bupropion—Dry skin—Thalidomide—leprosy	0.000544	0.00349	CcSEcCtD
Bupropion—Orthostatic hypotension—Thalidomide—leprosy	0.000542	0.00347	CcSEcCtD
Bupropion—Breast disorder—Thalidomide—leprosy	0.000536	0.00344	CcSEcCtD
Bupropion—Cramp muscle—Thalidomide—leprosy	0.000534	0.00342	CcSEcCtD
Bupropion—Muscular weakness—Thalidomide—leprosy	0.000523	0.00335	CcSEcCtD
Bupropion—Abdominal distension—Thalidomide—leprosy	0.000516	0.00331	CcSEcCtD
Bupropion—Insomnia—Dapsone—leprosy	0.000515	0.0033	CcSEcCtD
Bupropion—Influenza—Thalidomide—leprosy	0.000513	0.00329	CcSEcCtD
Bupropion—Dysphagia—Thalidomide—leprosy	0.000513	0.00329	CcSEcCtD
Bupropion—Bronchospasm—Thalidomide—leprosy	0.000504	0.00323	CcSEcCtD
Bupropion—Pancreatitis—Thalidomide—leprosy	0.000503	0.00322	CcSEcCtD
Bupropion—Bronchitis—Thalidomide—leprosy	0.000493	0.00316	CcSEcCtD
Bupropion—Pancytopenia—Thalidomide—leprosy	0.000487	0.00312	CcSEcCtD
Bupropion—Upper respiratory tract infection—Thalidomide—leprosy	0.000476	0.00306	CcSEcCtD
Bupropion—Pollakiuria—Thalidomide—leprosy	0.000474	0.00304	CcSEcCtD
Bupropion—Erectile dysfunction—Thalidomide—leprosy	0.000472	0.00303	CcSEcCtD
Bupropion—Photosensitivity reaction—Thalidomide—leprosy	0.000468	0.003	CcSEcCtD
Bupropion—Weight increased—Thalidomide—leprosy	0.000467	0.00299	CcSEcCtD
Bupropion—Gastrointestinal pain—Dapsone—leprosy	0.000466	0.00299	CcSEcCtD
Bupropion—Weight decreased—Thalidomide—leprosy	0.000464	0.00297	CcSEcCtD
Bupropion—Hyperglycaemia—Thalidomide—leprosy	0.000462	0.00297	CcSEcCtD
Bupropion—SLC6A3—nerve—leprosy	0.000461	0.117	CbGeAlD
Bupropion—Pneumonia—Thalidomide—leprosy	0.00046	0.00295	CcSEcCtD
Bupropion—Infestation—Thalidomide—leprosy	0.000457	0.00293	CcSEcCtD
Bupropion—Infestation NOS—Thalidomide—leprosy	0.000457	0.00293	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000453	0.00291	CcSEcCtD
Bupropion—Acute coronary syndrome—Thalidomide—leprosy	0.000451	0.00289	CcSEcCtD
Bupropion—Abdominal pain—Dapsone—leprosy	0.00045	0.00289	CcSEcCtD
Bupropion—Body temperature increased—Dapsone—leprosy	0.00045	0.00289	CcSEcCtD
Bupropion—Myocardial infarction—Thalidomide—leprosy	0.000448	0.00287	CcSEcCtD
Bupropion—Neuropathy peripheral—Thalidomide—leprosy	0.000448	0.00287	CcSEcCtD
Bupropion—Stomatitis—Thalidomide—leprosy	0.000446	0.00286	CcSEcCtD
Bupropion—Conjunctivitis—Thalidomide—leprosy	0.000444	0.00285	CcSEcCtD
Bupropion—Sweating—Thalidomide—leprosy	0.000438	0.00281	CcSEcCtD
Bupropion—Epistaxis—Thalidomide—leprosy	0.000431	0.00276	CcSEcCtD
Bupropion—Sinusitis—Thalidomide—leprosy	0.000429	0.00275	CcSEcCtD
Bupropion—Rhinitis—Thalidomide—leprosy	0.000411	0.00264	CcSEcCtD
Bupropion—Hepatitis—Thalidomide—leprosy	0.00041	0.00263	CcSEcCtD
Bupropion—Hypoaesthesia—Thalidomide—leprosy	0.000408	0.00262	CcSEcCtD
Bupropion—Pharyngitis—Thalidomide—leprosy	0.000407	0.00261	CcSEcCtD
Bupropion—Urinary tract disorder—Thalidomide—leprosy	0.000405	0.0026	CcSEcCtD
Bupropion—Oedema peripheral—Thalidomide—leprosy	0.000404	0.00259	CcSEcCtD
Bupropion—Urethral disorder—Thalidomide—leprosy	0.000402	0.00258	CcSEcCtD
Bupropion—Visual impairment—Thalidomide—leprosy	0.000395	0.00254	CcSEcCtD
Bupropion—Erythema multiforme—Thalidomide—leprosy	0.000388	0.00249	CcSEcCtD
Bupropion—Eye disorder—Thalidomide—leprosy	0.000383	0.00246	CcSEcCtD
Bupropion—Tinnitus—Thalidomide—leprosy	0.000383	0.00245	CcSEcCtD
Bupropion—Cardiac disorder—Thalidomide—leprosy	0.000381	0.00244	CcSEcCtD
Bupropion—Angiopathy—Thalidomide—leprosy	0.000372	0.00239	CcSEcCtD
Bupropion—SLC6A2—nerve—leprosy	0.000372	0.0941	CbGeAlD
Bupropion—Immune system disorder—Thalidomide—leprosy	0.000371	0.00238	CcSEcCtD
Bupropion—Mediastinal disorder—Thalidomide—leprosy	0.00037	0.00237	CcSEcCtD
Bupropion—Chills—Thalidomide—leprosy	0.000368	0.00236	CcSEcCtD
Bupropion—Arrhythmia—Thalidomide—leprosy	0.000367	0.00235	CcSEcCtD
Bupropion—Alopecia—Thalidomide—leprosy	0.000363	0.00233	CcSEcCtD
Bupropion—Vomiting—Dapsone—leprosy	0.000362	0.00232	CcSEcCtD
Bupropion—Mental disorder—Thalidomide—leprosy	0.000359	0.00231	CcSEcCtD
Bupropion—Malnutrition—Thalidomide—leprosy	0.000357	0.00229	CcSEcCtD
Bupropion—Headache—Dapsone—leprosy	0.000357	0.00229	CcSEcCtD
Bupropion—Flatulence—Thalidomide—leprosy	0.000352	0.00226	CcSEcCtD
Bupropion—Tension—Thalidomide—leprosy	0.00035	0.00225	CcSEcCtD
Bupropion—Dysgeusia—Thalidomide—leprosy	0.00035	0.00224	CcSEcCtD
Bupropion—CHRNA3—eye—leprosy	0.000348	0.0882	CbGeAlD
Bupropion—Nervousness—Thalidomide—leprosy	0.000347	0.00222	CcSEcCtD
Bupropion—Back pain—Thalidomide—leprosy	0.000345	0.00222	CcSEcCtD
Bupropion—Muscle spasms—Thalidomide—leprosy	0.000343	0.0022	CcSEcCtD
Bupropion—Nausea—Dapsone—leprosy	0.000338	0.00217	CcSEcCtD
Bupropion—Vision blurred—Thalidomide—leprosy	0.000337	0.00216	CcSEcCtD
Bupropion—Tremor—Thalidomide—leprosy	0.000335	0.00215	CcSEcCtD
Bupropion—Ill-defined disorder—Thalidomide—leprosy	0.000331	0.00213	CcSEcCtD
Bupropion—Anaemia—Thalidomide—leprosy	0.00033	0.00212	CcSEcCtD
Bupropion—Agitation—Thalidomide—leprosy	0.000328	0.0021	CcSEcCtD
Bupropion—Angioedema—Thalidomide—leprosy	0.000326	0.00209	CcSEcCtD
Bupropion—Malaise—Thalidomide—leprosy	0.000322	0.00207	CcSEcCtD
Bupropion—Vertigo—Thalidomide—leprosy	0.000321	0.00206	CcSEcCtD
Bupropion—Syncope—Thalidomide—leprosy	0.00032	0.00205	CcSEcCtD
Bupropion—Leukopenia—Thalidomide—leprosy	0.00032	0.00205	CcSEcCtD
Bupropion—Palpitations—Thalidomide—leprosy	0.000316	0.00202	CcSEcCtD
Bupropion—Loss of consciousness—Thalidomide—leprosy	0.000314	0.00201	CcSEcCtD
Bupropion—Cough—Thalidomide—leprosy	0.000312	0.002	CcSEcCtD
Bupropion—Convulsion—Thalidomide—leprosy	0.000309	0.00198	CcSEcCtD
Bupropion—Hypertension—Thalidomide—leprosy	0.000308	0.00198	CcSEcCtD
Bupropion—Chest pain—Thalidomide—leprosy	0.000304	0.00195	CcSEcCtD
Bupropion—Arthralgia—Thalidomide—leprosy	0.000304	0.00195	CcSEcCtD
Bupropion—Myalgia—Thalidomide—leprosy	0.000304	0.00195	CcSEcCtD
Bupropion—Anxiety—Thalidomide—leprosy	0.000303	0.00194	CcSEcCtD
Bupropion—CHRNA3—skin of body—leprosy	0.000303	0.0767	CbGeAlD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000302	0.00194	CcSEcCtD
Bupropion—Discomfort—Thalidomide—leprosy	0.0003	0.00193	CcSEcCtD
Bupropion—Dry mouth—Thalidomide—leprosy	0.000297	0.00191	CcSEcCtD
Bupropion—Confusional state—Thalidomide—leprosy	0.000294	0.00188	CcSEcCtD
Bupropion—Oedema—Thalidomide—leprosy	0.000292	0.00187	CcSEcCtD
Bupropion—Infection—Thalidomide—leprosy	0.00029	0.00186	CcSEcCtD
Bupropion—Shock—Thalidomide—leprosy	0.000287	0.00184	CcSEcCtD
Bupropion—Nervous system disorder—Thalidomide—leprosy	0.000286	0.00183	CcSEcCtD
Bupropion—Thrombocytopenia—Thalidomide—leprosy	0.000285	0.00183	CcSEcCtD
Bupropion—Tachycardia—Thalidomide—leprosy	0.000284	0.00182	CcSEcCtD
Bupropion—Skin disorder—Thalidomide—leprosy	0.000283	0.00182	CcSEcCtD
Bupropion—Hyperhidrosis—Thalidomide—leprosy	0.000282	0.00181	CcSEcCtD
Bupropion—Anorexia—Thalidomide—leprosy	0.000278	0.00178	CcSEcCtD
Bupropion—Hypotension—Thalidomide—leprosy	0.000272	0.00175	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Thalidomide—leprosy	0.000266	0.0017	CcSEcCtD
Bupropion—Insomnia—Thalidomide—leprosy	0.000264	0.00169	CcSEcCtD
Bupropion—Paraesthesia—Thalidomide—leprosy	0.000262	0.00168	CcSEcCtD
Bupropion—Dyspnoea—Thalidomide—leprosy	0.00026	0.00167	CcSEcCtD
Bupropion—Somnolence—Thalidomide—leprosy	0.000259	0.00166	CcSEcCtD
Bupropion—Dyspepsia—Thalidomide—leprosy	0.000257	0.00165	CcSEcCtD
Bupropion—Decreased appetite—Thalidomide—leprosy	0.000253	0.00163	CcSEcCtD
Bupropion—Gastrointestinal disorder—Thalidomide—leprosy	0.000252	0.00161	CcSEcCtD
Bupropion—Fatigue—Thalidomide—leprosy	0.000251	0.00161	CcSEcCtD
Bupropion—Constipation—Thalidomide—leprosy	0.000249	0.0016	CcSEcCtD
Bupropion—Pain—Thalidomide—leprosy	0.000249	0.0016	CcSEcCtD
Bupropion—Feeling abnormal—Thalidomide—leprosy	0.00024	0.00154	CcSEcCtD
Bupropion—Gastrointestinal pain—Thalidomide—leprosy	0.000238	0.00153	CcSEcCtD
Bupropion—Urticaria—Thalidomide—leprosy	0.000232	0.00149	CcSEcCtD
Bupropion—Body temperature increased—Thalidomide—leprosy	0.00023	0.00148	CcSEcCtD
Bupropion—Abdominal pain—Thalidomide—leprosy	0.00023	0.00148	CcSEcCtD
Bupropion—Hypersensitivity—Thalidomide—leprosy	0.000215	0.00138	CcSEcCtD
Bupropion—Asthenia—Thalidomide—leprosy	0.000209	0.00134	CcSEcCtD
Bupropion—Pruritus—Thalidomide—leprosy	0.000206	0.00132	CcSEcCtD
Bupropion—Diarrhoea—Thalidomide—leprosy	0.000199	0.00128	CcSEcCtD
Bupropion—Dizziness—Thalidomide—leprosy	0.000193	0.00124	CcSEcCtD
Bupropion—CHRNA3—testis—leprosy	0.000191	0.0484	CbGeAlD
Bupropion—CHRNA3—nervous system—leprosy	0.000187	0.0475	CbGeAlD
Bupropion—Vomiting—Thalidomide—leprosy	0.000185	0.00119	CcSEcCtD
Bupropion—Rash—Thalidomide—leprosy	0.000184	0.00118	CcSEcCtD
Bupropion—Dermatitis—Thalidomide—leprosy	0.000184	0.00118	CcSEcCtD
Bupropion—Headache—Thalidomide—leprosy	0.000183	0.00117	CcSEcCtD
Bupropion—Nausea—Thalidomide—leprosy	0.000173	0.00111	CcSEcCtD
Bupropion—ORM1—nervous system—leprosy	0.000111	0.0282	CbGeAlD
Bupropion—SLC6A3—testis—leprosy	0.000106	0.0267	CbGeAlD
Bupropion—SLC6A3—nervous system—leprosy	0.000104	0.0262	CbGeAlD
Bupropion—CYP2B6—skin of body—leprosy	9.96e-05	0.0252	CbGeAlD
Bupropion—SLC6A2—testis—leprosy	8.52e-05	0.0216	CbGeAlD
Bupropion—SLC6A2—nervous system—leprosy	8.36e-05	0.0212	CbGeAlD
Bupropion—CYP2E1—tendon—leprosy	7.11e-05	0.018	CbGeAlD
Bupropion—CYP2C8—testis—leprosy	7e-05	0.0177	CbGeAlD
Bupropion—CYP2B6—testis—leprosy	6.28e-05	0.0159	CbGeAlD
Bupropion—CYP2B6—nervous system—leprosy	6.16e-05	0.0156	CbGeAlD
Bupropion—CYP2E1—testis—leprosy	5.89e-05	0.0149	CbGeAlD
Bupropion—CYP2E1—nervous system—leprosy	5.78e-05	0.0146	CbGeAlD
Bupropion—CYP2D6—testis—leprosy	4.66e-05	0.0118	CbGeAlD
Bupropion—CYP3A4—nervous system—leprosy	4.65e-05	0.0118	CbGeAlD
Bupropion—CYP2D6—nervous system—leprosy	4.58e-05	0.0116	CbGeAlD
